TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 13, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 2
- −1 vs. Q2 2025
- Portfolio value
- $274.0M
- +$110.6M (+67.7%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | COM | 6,073,958 | $157.5M | 57.5% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 13,863,975 | $116.5M | 42.5% | −2,995,100−17.8% | Reduced | History |
Sold out since Q2 2025 (1)
Positions held at the end of Q2 2025 that are gone from this filing.